Drug
Telmisartan
Telmisartan: highest development phase Phase 3, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| Telmisartan NCT02177409 | Phase 3 | Hypertension |
Latest
No recent events.
Follow Telmisartan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.